Favoring the Concept of Chronic CAD Over Stable CAD
Individuals with CAD who have not experienced a recent CV event are generally considered to have stable CAD.
Acute Coronary Syndrome
Thromboembolic Disorder Treatments
Anticoagulants, antiplatelets, and thrombolytics for the treatment and/or prophylaxis of venous and arterial thrombosis.
Risk for PAD Events May Be Related to Lipoprotein(a) Levels, Reduced by Alirocumab After ACS
The risk for peripheral artery disease events was found to be associated with levels of lipoprotein(a) in patients with recent acute coronary syndrome.
Two-Thirds of Patients Treated With Statins for ACS May Not to Achieve Recommended LDL-C Target
The majority of patients with acute coronary syndrome treated with statins were found to have low-density lipoproteins-cholesterol levels above those recommended by current guidelines.
Indigenous Australian Status May Be a Predictor of Mortality After ACS
Aboriginal and Torres Strait Islander status may predict death in individuals with acute coronary syndrome.
Incidence of Muscle Complaints Not Found to Increase When Adding Ezetimibe to Simvastatin After ACS
The addition of the ezetimibe to simvastatin in patients with a recent acute coronary syndrome was not found to be associated with an increased incidence of patient-reported muscle complaints.
Improving Outcomes of Early Myocardial Infarction Rule-Out in the ED
In the early rule-out of myocardial infarction, outcomes may be improved by accounting for the patient’s out-of-hospital experience, improving reassurance communication, and discussing future goals for cardiovascular health.
Impaired Renal Function Found to Affect Long-Term Prognosis After PCI
Impaired renal function was found to have negative long-term effects in individuals with acute coronary syndrome after percutaneous coronary intervention.
Identification of Factors Associated With Contrast-Induced Nephropathy After PCI
Several factors were found to be associated with the development of contrast-induced nephropathy after percutaneous coronary intervention in patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome.
Elevated Cardiovascular Disease Risk in Patients With Inflammatory Arthritis
Researchers assessed the prevalence and incidence rate of cardiovascular morbidity in patients with inflammatory arthritis and determined whether the coexistence of multiple autoimmune disorders was associated with increased risk for cardiovascular disease.
-
Loading...
-
Loading...
